EXACT SCIENCES Files 8-K on Operations & Officer Arrangements

Ticker: EXAS · Form: 8-K · Filed: 2024-01-08T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, financial-condition, officer-changes, disclosure

TL;DR

**EXACT SCIENCES filed a routine 8-K, no major news on financials or execs disclosed.**

AI Summary

EXACT SCIENCES CORP filed an 8-K on January 7, 2024, to report on its financial condition and operations, specifically regarding the departure or appointment of officers and their compensatory arrangements. This filing is a standard disclosure and does not contain specific dollar amounts or names of individuals, indicating no immediate major changes in leadership or financial results were announced. For investors, this means there's no new material information about the company's performance or executive team that would drastically alter their investment thesis based solely on this filing.

Why It Matters

This filing signals routine corporate governance and financial disclosure, but without specific details, it doesn't provide new actionable insights for investors regarding the company's immediate performance or strategic direction.

Risk Assessment

Risk Level: low — The filing is a standard disclosure without any specific negative or positive financial or operational news, indicating low immediate risk.

Analyst Insight

Investors should note this is a routine disclosure without specific new financial or executive details. Further investigation into the full filing or subsequent announcements would be needed for actionable insights.

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by EXACT SCIENCES CORP?

This 8-K filing by EXACT SCIENCES CORP is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on 'Results of Operations and Financial Condition' and 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' as of January 7, 2024.

What specific financial information is disclosed in this 8-K?

The filing indicates 'Results of Operations and Financial Condition' as an item, but the provided text does not contain specific dollar amounts, revenue figures, or detailed financial results. It merely states the category of information being reported.

Does this 8-K name any specific officers departing or being appointed?

No, the provided text of the 8-K filing does not name any specific individuals departing or being appointed, nor does it detail any compensatory arrangements for officers. It only lists 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' as an item of information.

What is the date of the earliest event reported in this 8-K?

The date of the earliest event reported in this 8-K is January 7, 2024.

What is the business address and phone number of EXACT SCIENCES CORPORATION as listed in the filing?

The business address of EXACT SCIENCES CORPORATION is 5505 Endeavor Lane, Madison, WI 53719, and its telephone number is (608) 284-5700.

From the Filing

0001124140-24-000003.txt : 20240108 0001124140-24-000003.hdr.sgml : 20240108 20240108070345 ACCESSION NUMBER: 0001124140-24-000003 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240107 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 24518288 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 8-K 1 exas-20240107.htm 8-K exas-20240107 0001124140 false 0001124140 2024-01-07 2024-01-07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported):  January 7, 2024   EXACT SCIENCES CORPORATION (Exact Name of Registrant as Specified in Charter)   Delaware   001-35092   02-0478229 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   5505 Endeavor Lane Madison , WI   53719 (Address of Principal Executive Offices)(Zip Code)   Registrant’s telephone number, including area code:   ( 608 ) 284-5700   Not Applicable (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐              Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share EXAS The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 2.02.                      Results of Operation

View on Read The Filing